# Sandra Pérez Baos

> Sandra Pérez Baos, Ph.D. is a Senior Associate at 2048 Ventures, a NYC- and Boston-based thesis-driven early-stage VC firm that closed an oversubscribed $82M Fund III in January 2026. A scientist turned investor, she brings a decade of hands-on experience in translational immunology and molecular biology research - first as a postdoctoral researcher at NYU Grossman School of Medicine, then as a founding leader at Nucleate New York, and later as a fellow with NYU's technology commercialization office. At 2048 Ventures she leads biotech and health investments at pre-seed and seed stages, writing checks from $500K to $3M into companies building the next generation of platform biology, drug delivery, diagnostics, and digital health.

- **Role:** Senior Associate at 2048 Ventures
- **Organizations:** 2048 Ventures, Nucleate New York, NYU Technology Opportunities and Ventures, NYU Grossman School of Medicine
- **From:** Spain
- **Nationality:** Spanish
- **Education:** B.S. in Biotechnology, Universidad de Salamanca, M.S. in Immunology, Universidad Complutense de Madrid, Ph.D. in Molecular Biosciences, Universidad Autónoma de Madrid, CORe Credential (Pass with High Honors), Harvard Business School Online
- **Known for:** Promoted to Senior Associate at 2048 Ventures upon close of oversubscribed $82M Fund III (January 2026), 32 published research papers in immunology and molecular biology, Founding member of Nucleate New York's leadership team, helping build one of the premier biotech entrepreneurship networks in NYC

## Career timeline

- **Pre-2019** — Completed B.S. in Biotechnology (Salamanca), M.S. in Immunology (Complutense de Madrid), and Ph.D. in Molecular Biosciences (Autónoma de Madrid) in Spain
- **2019** — Joined NYU Grossman School of Medicine as Postdoctoral Research Scientist, focusing on T cell mRNA translation and immunotherapy
- **2021-2023** — Joined founding leadership team at Nucleate New York as Mentor Relations Director and Tech Sourcing Lead, building the biotech talent and entrepreneurship network
- **2022-2023** — Served as Business Development Fellow at NYU Technology Opportunities and Ventures (TOV), learning to commercialize scientific IP
- **2023** — Helped co-found and launch a therapeutics startup during her postdoctoral fellowship at NYU Grossman
- **2023** — Joined 2048 Ventures, a NYC/Boston-based early-stage VC, to focus on biotech and health investments
- **2026-01** — 2048 Ventures closes oversubscribed $82,048,000 Fund III; Sandra promoted to Senior Associate

## Achievements

- Promoted to Senior Associate at 2048 Ventures upon close of oversubscribed $82M Fund III (January 2026)
- 32 published research papers in immunology and molecular biology
- Founding member of Nucleate New York's leadership team, helping build one of the premier biotech entrepreneurship networks in NYC
- Harvard Business School Online CORe Certificate with Pass with High Honors distinction
- Helped launch a therapeutics startup during postdoctoral fellowship at NYU Grossman School of Medicine
- Business Development Fellow at NYU Technology Opportunities and Ventures
- Spent decade in cutting-edge translational immunology research spanning T cell biology, cancer, and autoimmunity

## Latest updates

- **2026-01** — 2048 Ventures closes oversubscribed $82,048,000 Fund III; Sandra promoted to Senior Associate
- **2025-12** — Published analysis on biotech pharma M&A trends predicting a wave of mid-cap platform acquisitions in immunology and RNA biology in 2026
- **2024-03** — Promoted applications for the 2048 Ventures Biotech Fellowship on LinkedIn

## Links

- Website: https://www.2048.vc/team
- LinkedIn: https://www.linkedin.com/in/sperezbaos/
- Twitter/X: https://twitter.com/sperezbaos

---

Profile page: https://yespress.io/sandra-p-rez-baos
Published by YesPress — https://yespress.io
Last updated: 2026-05-12